SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 6/30/13 – ‘XML.R15’

On:  Friday, 8/9/13, at 5:20pm ET   ·   For:  6/30/13   ·   Accession #:  1193125-13-329393   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 11/14/12 for 9/30/12   ·   Next:  ‘10-Q’ on 11/8/13 for 9/30/13   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/13  Organovo Holdings, Inc.           10-Q        6/30/13   79:9.3M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    413K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Exhiibt 32.1                                        HTML     23K 
77: R1          Document and Entity Information                     HTML     42K 
48: R2          Condensed Consolidated Balance Sheets               HTML    104K 
44: R3          Condensed Consolidated Balance Sheets               HTML     34K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     75K 
                (Unaudited)                                                      
47: R5          Condensed Consolidated Statements of Stockholders'  HTML    125K 
                Equity (Deficit) (Unaudited)                                     
28: R6          Condensed Consolidated Statements of Cash Flows     HTML    128K 
                (Unaudited)                                                      
65: R7          Condensed Consolidated Statements of Cash Flows     HTML     45K 
                (Unaudited) (Parenthetical)                                      
29: R8          Change in Fiscal Year End                           HTML     25K 
34: R9          Description of Business and Summary of Significant  HTML     94K 
                Accounting Policies                                              
15: R10         Derivative Liability                                HTML     46K 
31: R11         Stockholders' Equity                                HTML     96K 
64: R12         Commitments and Contingencies                       HTML     44K 
59: R13         Concentrations                                      HTML     28K 
45: R14         Subsequent Events                                   HTML     33K 
72: R15         Description of Business and Summary of Significant  HTML    170K 
                Accounting Policies (Policies)                                   
62: R16         Description of Business and Summary of Significant  HTML     48K 
                Accounting Policies (Tables)                                     
13: R17         Derivative Liability (Tables)                       HTML     38K 
18: R18         Stockholders' Equity (Tables)                       HTML     86K 
71: R19         Commitments and Contingencies (Tables)              HTML     30K 
76: R20         Description of Business and Summary of Significant  HTML     33K 
                Accounting Policies (Details)                                    
78: R21         Description of Business and Summary of Significant  HTML     38K 
                Accounting Policies (Details 1)                                  
74: R22         Description of Business and Summary of Significant  HTML    240K 
                Accounting Policies (Details Textual)                            
56: R23         Derivative Liability (Details)                      HTML     36K 
16: R24         Derivative Liability (Details Textual)              HTML     44K 
27: R25         Stockholders' Equity (Details)                      HTML     34K 
22: R26         Stockholders' Equity (Details 1)                    HTML     58K 
21: R27         Stockholders' Equity (Details 2)                    HTML     36K 
35: R28         Stockholders' Equity (Details 3)                    HTML     50K 
55: R29         Stockholders' Equity (Details 4)                    HTML     27K 
61: R30         Stockholders' Equity (Details Textual)              HTML    273K 
24: R31         Commitments and Contingencies (Details)             HTML     35K 
36: R32         Commitments and Contingencies (Details Textual)     HTML     31K 
68: R33         Subsequent Events (Details Textual)                 HTML     66K 
43: XML         IDEA XML File -- Filing Summary                      XML     90K 
79: XML.R1      Document and Entity Information                      XML    121K 
33: XML.R2      Condensed Consolidated Balance Sheets                XML    279K 
54: XML.R3      Condensed Consolidated Balance Sheets                XML     89K 
                (Parenthetical)                                                  
42: XML.R4      Condensed Consolidated Statements of Operations      XML    294K 
                (Unaudited)                                                      
39: XML.R5      Condensed Consolidated Statements of Stockholders'   XML   1.71M 
                Equity (Deficit) (Unaudited)                                     
12: XML.R6      Condensed Consolidated Statements of Cash Flows      XML    504K 
                (Unaudited)                                                      
49: XML.R7      Condensed Consolidated Statements of Cash Flows      XML    142K 
                (Unaudited) (Parenthetical)                                      
11: XML.R8      Change in Fiscal Year End                            XML     40K 
25: XML.R9      Description of Business and Summary of Significant   XML    102K 
                Accounting Policies                                              
38: XML.R10     Derivative Liability                                 XML     58K 
30: XML.R11     Stockholders' Equity                                 XML    115K 
26: XML.R12     Commitments and Contingencies                        XML     54K 
66: XML.R13     Concentrations                                       XML     41K 
32: XML.R14     Subsequent Events                                    XML     44K 
75: XML.R15     Description of Business and Summary of Significant   XML    266K 
                Accounting Policies (Policies)                                   
51: XML.R16     Description of Business and Summary of Significant   XML     70K 
                Accounting Policies (Tables)                                     
50: XML.R17     Derivative Liability (Tables)                        XML     53K 
53: XML.R18     Stockholders' Equity (Tables)                        XML    127K 
23: XML.R19     Commitments and Contingencies (Tables)               XML     45K 
46: XML.R20     Description of Business and Summary of Significant   XML    304K 
                Accounting Policies (Details)                                    
60: XML.R21     Description of Business and Summary of Significant   XML    187K 
                Accounting Policies (Details 1)                                  
63: XML.R22     Description of Business and Summary of Significant   XML   4.68M 
                Accounting Policies (Details Textual)                            
67: XML.R23     Derivative Liability (Details)                       XML    155K 
37: XML.R24     Derivative Liability (Details Textual)               XML    258K 
20: XML.R25     Stockholders' Equity (Details)                       XML    101K 
69: XML.R26     Stockholders' Equity (Details 1)                     XML    221K 
52: XML.R27     Stockholders' Equity (Details 2)                     XML     90K 
70: XML.R28     Stockholders' Equity (Details 3)                     XML    297K 
17: XML.R29     Stockholders' Equity (Details 4)                     XML    124K 
58: XML.R30     Stockholders' Equity (Details Textual)               XML   6.50M 
57: XML.R31     Commitments and Contingencies (Details)              XML     73K 
19: XML.R32     Commitments and Contingencies (Details Textual)      XML     94K 
73: XML.R33     Subsequent Events (Details Textual)                  XML    658K 
40: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    716K 
 5: EX-101.INS  XBRL Instance -- onvo-20130630                       XML    957K 
 7: EX-101.CAL  XBRL Calculations -- onvo-20130630_cal               XML    139K 
 8: EX-101.DEF  XBRL Definitions -- onvo-20130630_def                XML    436K 
 9: EX-101.LAB  XBRL Labels -- onvo-20130630_lab                     XML    990K 
10: EX-101.PRE  XBRL Presentations -- onvo-20130630_pre              XML    714K 
 6: EX-101.SCH  XBRL Schema -- onvo-20130630                         XSD    147K 
41: ZIP         XBRL Zipped Folder -- 0001193125-13-329393-xbrl      Zip    118K 


‘XML.R15’   —   Description of Business and Summary of Significant Accounting Policies (Policies)


This Financial Report is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<InstanceReport xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<Version> 2.4.0.8 </Version>
<ReportLongName> 0402 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) </ReportLongName>
<DisplayLabelColumn> true </DisplayLabelColumn>
<ShowElementNames> false </ShowElementNames>
<RoundingOption/>
<HasEmbeddedReports> false </HasEmbeddedReports>
<Columns>
<Column FlagID="0">
<Id> 1 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<CurrencyCode/>
<FootnoteIndexer/>
<hasSegments> false </hasSegments>
<hasScenarios> false </hasScenarios>
<MCU>
<KeyName/>
<CurrencySymbol/>
<contextRef>
<ContextID> Apr_01_2013_Jun_30_2013 </ContextID>
<EntitySchema> http://www.sec.gov/CIK </EntitySchema>
<EntityValue> 0001497253 </EntityValue>
<PeriodDisplayName/>
<PeriodType> duration </PeriodType>
<PeriodStartDate> 2013-04-01T00:00:00 </PeriodStartDate>
<PeriodEndDate> 2013-06-30T00:00:00 </PeriodEndDate>
<Segments/>
<Scenarios/>
</contextRef>
<UPS/>
<CurrencyCode/>
<OriginalCurrencyCode/>
</MCU>
<CurrencySymbol/>
<Labels>
<Label Key="CalendarSupplement" Id="0" Label="3 Months Ended"/>
<Label Key="Calendar" Id="1" Label="Jun. 30, 2013"/>
</Labels>
</Column>
</Columns>
<Rows>
<Row FlagID="0">
<Id> 1 </Id>
<IsAbstractGroupTitle> true </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 1 </Level>
<ElementName> us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText/>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> xbrli:stringItemType </ElementDataType>
<SimpleDataType> string </SimpleDataType>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Change in Fiscal Year End [Abstract] </Label>
</Row>
<Row FlagID="0">
<Id> 2 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> onvo_NatureOfOperationsAndBasisOfPresentationPolicyTextBlock </ElementName>
<ElementPrefix> onvo_ </ElementPrefix>
<IsBaseElement> false </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table1 - onvo:NatureOfOperationsAndBasisOfPresentationPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Nature of operations and basis of presentation </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">References in these notes to the unaudited condensed financial statements to “Organovo Holdings, Inc.,” “Organovo Holdings,” “we,” “us,” “our,” “the Company” and “our Company” refer to Organovo Holdings, Inc. and its consolidated subsidiary Organovo, Inc. The Company is developing and commercializing functional three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">As of June 30, 2013, the Company has devoted substantially all of its efforts to product development, raising capital, and building infrastructure. The Company has not realized significant revenues from its planned principal operations. Accordingly, the Company is considered to be in the development stage. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The accompanying interim condensed financial statements have been prepared by the Company, without audit, in accordance with the instructions to Form 10-Q and, therefore, do not necessarily include all information and footnotes necessary for a fair statement of its financial position, results of operations, stockholders’ equity (deficit) and cash flows in accordance with generally accepted accounting principles (“GAAP”). The balance sheet at March 31, 2013 is derived from the audited balance sheet at that date. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, which are only normal and recurring, necessary for a fair statement of the Company’s financial position, results of operations, stockholders’ equity (deficit) and cash flows. These financial statements should be read in conjunction with the financial statements included in the Company’s Transition Report filed on Form 10-KT for the transition period ended March 31, 2013 filed with the Securities and Exchange Commission (the “SEC”) on May 24, 2013. Operating results for interim periods are not necessarily indicative of operating results for the Company’s fiscal year ending March 31, 2014. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Nature of operations and basis of presentation. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Nature of operations and basis of presentation </Label>
</Row>
<Row FlagID="0">
<Id> 3 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table2 - us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Reverse merger transaction </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">On February 8, 2012, Organovo, Inc., a privately held Delaware corporation, merged with and into Organovo Acquisition Corp., a wholly-owned subsidiary of Organovo Holdings, Inc., a publicly traded Delaware corporation, with Organovo, Inc. surviving the merger as a wholly-owned subsidiary of the Company (the “Merger”). As a result of the Merger, the Company acquired the business of Organovo, Inc., and will continue the existing business operations of Organovo, Inc. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Simultaneously with the Merger, on February 8, 2012 (the “closing date”), all of the issued and outstanding shares of Organovo, Inc.’s common stock converted, on a 1 for 1 basis, into shares of the Company’s common stock, par value $0.001 per share. Also, on the closing date, all of the issued and outstanding options to purchase shares of Organovo, Inc.’s common stock and other outstanding warrants to purchase Organovo, Inc.’s common stock, and all of the issued and outstanding bridge warrants to purchase shares of Organovo, Inc.’s common stock, converted on a 1 for 1 basis, into options, warrants and new bridge warrants to purchase shares of the Company’s common stock. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Immediately following the consummation of the Merger: (i) the former security holders of Organovo, Inc. common stock had an approximate 75% voting interest in the Company and the Company stockholders retained an approximate 25% voting interest, (ii) the former executive management team of Organovo, Inc. remained as the only continuing executive management team for the Company, and (iii) the Company’s ongoing operations consist solely of the ongoing operations of Organovo, Inc. Based primarily on these factors, the Merger was accounted for as a reverse merger and a recapitalization in accordance with GAAP. As a result, these financial statements reflect the historical results of Organovo, Inc. prior to the Merger, and the combined results of the Company following the Merger. The par value of Organovo, Inc. common stock immediately prior to the Merger was $0.0001 per share. The par value subsequent to the Merger is $0.001 per share, and therefore the historical results of Organovo, Inc. prior to the Merger have been retroactively adjusted to affect the change in par value. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> In connection with three separate closings of a private placement transaction completed in connection with the Merger (the “Private Placement”), the Company received gross proceeds of approximately $5.0 million, $1.8 million and $6.9 million on closings on February 8, 2012, February 29, 2012 and March 16, 2012, respectively. In 2011, the Company received $1.5 million from the purchase of 6% convertible notes which were automatically converted into 1,500,000 shares of common stock, plus 25,387 shares for accrued interest of $25,387 on the principal, on February 8, 2012. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The cash transaction costs related to the Merger were approximately $2.1 million. </font></p> <p style="font-size:1px;margin-top:12px;margin-bottom:0px"> </p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Before the Merger, Organovo Holdings’ Board of Directors and stockholders adopted the 2012 Equity Incentive Plan (the “2012 Plan”). The 2012 Plan provides for the issuance of 6,553,986 shares of the Company’s common stock to executive officers, directors, advisory board members and employees. In addition, Organovo Holdings assumed and adopted Organovo, Inc.’s 2008 Equity Incentive Plan, which provided for the issuance of 896,256 shares of common stock, for total shares available for issuance under these plans of 7,450,242. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2303973 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Reverse merger transaction </Label>
</Row>
<Row FlagID="0">
<Id> 4 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_LiquidityDisclosureTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table3 - us-gaap:LiquidityDisclosureTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Liquidity </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> As of June 30, 2013, the Company had an accumulated deficit of approximately $70.1 million. The Company also had negative cash flows from operations of approximately $2.7 million during the three months ended June 30, 2013. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">On February 8, 2012, the Company received gross proceeds of approximately $5.0 million from the initial closing of a private placement offering in conjunction with the Merger (the “Private Placement”). On February 29, 2012 and March 16, 2012, the Company completed two additional closings of its Private Placement receiving gross proceeds of approximately $1.8 million and $6.9 million, respectively. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In December 2012, the Company consummated a warrant tender offer to the holders of outstanding warrants to purchase approximately 14.5 million shares of the Company’s common stock. The Company completed the tender offer on December 21, 2012, resulting in approximately 9.6 million warrants being exercised for gross proceeds of approximately $7.7 million. On February 5, 2013, the Company provided a Notice of Redemption to affected warrant holders, of approximately 2.4 million warrant shares, that they would have until March 14, 2013 to exercise their outstanding warrants at $1.00 per share. Thereafter, any warrants that remained unexercised would have been automatically redeemed by the Company at a redemption price of $0.0001 per share of common stock then issuable upon exercise of the redeemed warrant. As of March 14, 2013, all redeemable warrants had been exercised for net proceeds of approximately $2.3 million. During the three months ended March 31, 2013, the Company also received approximately $1.4 million of additional proceeds from the exercise of other warrants unrelated to the Redemption Notification. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Through June 30, 2013, the Company has financed its operations primarily through the sale of convertible notes, the private placement of equity securities, and through revenue derived from grants or collaborative research agreements. Based on its current operating plan and available cash resources, the Company has sufficient resources to fund its business for at least the next 12 months. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Moreover, subsequent to June 30, 2013, the Company raised net proceeds of approximately $43.3 million through the sale of 10,350,000 shares of its common stock in a public offering. Refer to Note 7, “Subsequent Events” below. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company cannot predict with certainty when, if ever, it will require additional capital to further fund the product development and commercialization of its human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The Company intends to cover its future operating expenses through cash on hand, and from revenue derived from grants and collaborative research agreements. However, the Company cannot provide assurance that it will not require additional funding in the future. In addition, the Company cannot be sure that additional financing will be available if and when needed, or that, if available, financing will be obtained on terms favorable to the Company and its stockholders. Having insufficient funds may require the Company to delay, scale back, or eliminate some or all of its development programs or relinquish rights to its technology on less favorable terms than it would otherwise choose. Failure to obtain adequate financing could eventually adversely affect the Company’s ability to operate as a going concern. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Liquidity </Label>
</Row>
<Row FlagID="0">
<Id> 5 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_UseOfEstimates </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table4 - us-gaap:UseOfEstimates--> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Use of estimates </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Use of estimates </Label>
</Row>
<Row FlagID="0">
<Id> 6 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_FairValueOfFinancialInstrumentsPolicy </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table5 - us-gaap:FairValueOfFinancialInstrumentsPolicy--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Financial instruments </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> For certain of the Company’s financial instruments, including cash and cash equivalents, grants receivable, inventory, prepaid expenses and other assets, accounts payable, accrued expenses, deferred revenue and capital lease obligations, the carrying amounts are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for determining the fair value of financial instruments. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155942 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Financial instruments </Label>
</Row>
<Row FlagID="0">
<Id> 7 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_CashAndCashEquivalentsPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table6 - us-gaap:CashAndCashEquivalentsPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Cash and cash equivalents </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company considers all highly liquid investments with original maturities of 90 days or less to be cash equivalents. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 305 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2122427 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Financial Reporting Release (FRR) -Number 203 -Paragraph 02-03 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Cash and cash equivalents </Label>
</Row>
<Row FlagID="0">
<Id> 8 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_DerivativesPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table7 - us-gaap:DerivativesPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Derivative financial instruments </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company reviews the terms of convertible debt and equity instruments it issues to determine whether there are derivative instruments, including an embedded conversion option that is required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where a host instrument contains more than one embedded derivative instrument, including a conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Also, in connection with the sale of convertible debt and equity instruments, the Company may issue freestanding warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Derivative instruments are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the convertible debt or equity instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds allocated to the convertible host instruments are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the convertible instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to interest expense, using the effective interest method. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for its derivative instruments and hedging activities. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph n -Article 4 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41675-113959 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Derivative financial instruments </Label>
</Row>
<Row FlagID="0">
<Id> 9 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table8 - us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Restricted cash </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">As of June 30, 2013 and March 31, 2013, the Company had approximately $38,300 and $88,300, respectively, of restricted cash deposited with a financial institution. $38,300 is held in certificates of deposit to support a letter of credit agreement related to the facility lease entered into during 2012. The additional $50,000 included in the March 31, 2013 balance represents funds held by the financial institution as a guarantee for the Company’s commercial credit cards. These funds were released from restriction during the three months ended June 30, 2013 as a result of the Company transferring its credit card program to a different financial institution. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 305 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2122427 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.1(a)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Subparagraph a -Article 9 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Financial Reporting Release (FRR) -Number 203 -Paragraph 02-03 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Restricted cash </Label>
</Row>
<Row FlagID="0">
<Id> 10 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> onvo_GrantsReceivablePolicyTextBlock </ElementName>
<ElementPrefix> onvo_ </ElementPrefix>
<IsBaseElement> false </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table9 - onvo:GrantsReceivablePolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Grant receivable </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Grant receivable represents the amount due from the National Institutes of Health (“NIH”) under a research grant. The Company considers the grant receivable to be fully collectible; and accordingly, no allowance for doubtful amounts has been established. If amounts become uncollectible, they are charged to operations. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Grants receivable. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Grant receivable </Label>
</Row>
<Row FlagID="0">
<Id> 11 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_InventoryPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table10 - us-gaap:InventoryPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Inventory </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Inventories are stated at the lower of the cost or market (first-in, first-out). Inventory at June 30, 2013 and March 31, 2013 consisted of approximately $85,000 and 88,000 in raw materials, respectively. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company provides inventory allowances based on excess or obsolete inventories determined based on anticipated use in the final product. There was no obsolete inventory reserve as of June 30, 2013 or March 31, 2013. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2126999 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Financial Reporting Release (FRR) -Number 206 -Paragraph b -Subparagraph i, ii -Chapter 2 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Inventory </Label>
</Row>
<Row FlagID="0">
<Id> 12 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table11 - us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Fixed assets and depreciation </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Property and equipment are carried at cost. Expenditures that extend the life of the asset are capitalized and depreciated. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the related assets or, in the case of leasehold improvements, over the lesser of the useful life of the related asset or the lease term. The estimated useful lives of the fixed assets range between two and five years. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Fixed assets and depreciation </Label>
</Row>
<Row FlagID="0">
<Id> 13 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table12 - us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock--> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Impairment of long-lived assets </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In accordance with authoritative guidance, the Company reviews its long-lived assets, including property and equipment and other assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be fully recoverable. To determine recoverability of its long-lived assets, the Company evaluates whether future undiscounted net cash flows will be less than the carrying amount of the assets and adjusts the carrying amount of its assets to fair value. Management has determined that no impairment of long-lived assets occurred in the period from inception through June 30, 2013. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section CC -Subsection 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155824 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Impairment of long-lived assets </Label>
</Row>
<Row FlagID="0">
<Id> 14 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_FairValueMeasurementPolicyPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table13 - us-gaap:FairValueMeasurementPolicyPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Fair value measurement </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Financial assets and liabilities are measured at fair value, which is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The following is a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value: </font></p> <p style="font-size:6px;margin-top:0px;margin-bottom:0px"> </p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="2"></font></td> <td width="1%" valign="top"><font size="1"> </font></td> <td align="left" valign="top"> <p align="left"><font style="font-family:times new roman" size="2">Level 1 — Quoted prices in active markets for identical assets or liabilities. </font></p> </td> </tr> </table> <p style="font-size:6px;margin-top:0px;margin-bottom:0px"> </p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="2"></font></td> <td width="1%" valign="top"><font size="1"> </font></td> <td align="left" valign="top"> <p align="left"><font style="font-family:times new roman" size="2">Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </font></p> </td> </tr> </table> <p style="font-size:6px;margin-top:0px;margin-bottom:0px"> </p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="2"></font></td> <td width="1%" valign="top"><font size="1"> </font></td> <td align="left" valign="top"> <p align="left"><font style="font-family:times new roman" size="2">Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </font></p> </td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company has issued warrants, of which some are classified as derivative liabilities as a result of the terms in the warrants that provide for down-round protection in the event of a dilutive issuance. The Company uses Level 3 inputs for its valuation methodology for the warrant derivative liabilities. The estimated fair values were determined using a Monte Carlo option pricing model based on various assumptions (see Note 3). The Company’s derivative liabilities are adjusted to reflect estimated fair value at each period end, with any decrease or increase in the estimated fair value being recorded in other income or expense accordingly, as adjustments to the fair value of derivative liabilities. Various factors are considered in the pricing models the Company uses to value the warrants, including the Company’s current stock price, the remaining life of the warrants, the volatility of the Company’s stock price, and the risk-free interest rate. Future changes in these factors will have a significant impact on the computed fair value of the warrant liability. As such, the Company expects future changes in the fair value of the warrants to continue to vary significantly from quarter to quarter. </font></p> <p style="font-size:1px;margin-top:12px;margin-bottom:0px"> </p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The estimated fair values of the liabilities measured on a recurring basis are as follows: </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px"> </p> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="70%"> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Fair Value Measurements at June 30 and March 31, 2013  (in thousands):</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Balance at<br />June 30,<br />2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Quoted<br />Prices in<br />Active<br />Markets<br />(Level 1)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Significant<br />Other<br />Observable<br />Inputs<br />(Level 2)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Significant<br />Other<br />Unobservable<br />Inputs<br />(Level 3)</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px"> </p> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="62%"> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="6%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td height="16"> </td> <td height="16" colspan="4"> </td> <td height="16" colspan="4"> </td> <td height="16" colspan="4"> </td> <td height="16" colspan="4"> </td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Balance at<br />March 31,<br />2013</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Quoted<br />Prices in<br />Active<br />Markets<br />(Level 1)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Significant<br />Other<br />Observable<br />Inputs<br />(Level 2)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Significant<br />Other<br />Unobservable<br />Inputs<br />(Level 3)</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,898</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,898</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <!-- End Table Body --> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The following table presents the activity for liabilities measured at estimated fair value using unobservable inputs for 2012 through June 30, 2013: </font></p> <p style="margin-top:24px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="2"><b>Fair Value Measurements Using Significant Unobservable Inputs (Level 3) </b></font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px"> </p> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="87%"> </td> <td valign="bottom" width="8%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Warrant<br />Derivative<br />Liability<br />($000’s)</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Balance at December 31, 2011</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,267</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Issuances</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">32,742</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Adjustments to estimated fair value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">9,931</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability removal due to settlements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(23,321</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">) </font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Balance at December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">20,619</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Issuances</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Adjustments to estimated fair value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,034</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability removal due to settlements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(23,869</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">) </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability reclassified to equity</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(1,886</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">) </font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Balance at March 31, 2013</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,898</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Issuances</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">  </font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Adjustments to estimated fair value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability removal due to settlements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(129</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">) </font></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Warrant liability reclassified to equity</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(767</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">) </font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000"> </p> </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Balance at June 30, 2013</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2"> </font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="border-top:3px double #000000"> </p> </td> <td valign="bottom"> <p style="border-top:3px double #000000"> </p> </td> <td> </td> </tr> <!-- End Table Body --> </table>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Fair value measurement </Label>
</Row>
<Row FlagID="0">
<Id> 15 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_ResearchAndDevelopmentExpensePolicy </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table14 - us-gaap:ResearchAndDevelopmentExpensePolicy--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Research and development </i> </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Research and development expenses, including direct and allocated expenses, consist of independent research and development costs, as well as costs associated with sponsored research and development. Research and development costs are expensed as incurred. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2127266 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Research and Development -URI http://asc.fasb.org/extlink&oid=6523717 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Research and development </Label>
</Row>
<Row FlagID="0">
<Id> 16 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_IncomeTaxPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table15 - us-gaap:IncomeTaxPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Income taxes </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Deferred income taxes are recognized for the tax consequences in future years for differences between the tax basis of assets and liabilities and their financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the combination of the tax payable for the year and the change during the year in deferred tax assets and liabilities. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144681 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -URI http://asc.fasb.org/subtopic&trid=2144749 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 740 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32247-109318 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32280-109318 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Income taxes </Label>
</Row>
<Row FlagID="0">
<Id> 17 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_RevenueRecognitionPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table16 - us-gaap:RevenueRecognitionPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Revenue recognition </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company’s revenues are derived from collaborative research agreements, NIH and U.S. Treasury Department Grants, the sale of bioprinter related products and services, and license agreements. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company recognizes revenue when the following criteria have been met: (i) persuasive evidence of an arrangement exists; (ii) services have been rendered or product has been delivered; (iii) price to the customer is fixed and determinable; and (iv) collection of the underlying receivable is reasonably assured. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Billings to customers or payments received from customers are included in deferred revenue on the balance sheet until all revenue recognition criteria are met. As of June 30, 2013 and March 31, 2013, the Company had approximately $36,000 and $62,000, respectively, in deferred revenue related to its collaborative research programs. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Revenue recognition </Label>
</Row>
<Row FlagID="0">
<Id> 18 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_RevenueRecognitionSalesOfGoods </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table17 - us-gaap:RevenueRecognitionSalesOfGoods--> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Product Revenue </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. The Company recognizes product revenues upon shipment to distributors, provided that (i) the price is substantially fixed or determinable at the time of sale; (ii) the distributor’s obligation to pay the Company is not contingent upon resale of the products; (iii) title and risk of loss passes to the distributor at time of shipment; (iv) the distributor has economic substance apart from that provided by the Company; (v) the Company has no significant obligation to the distributor to bring about resale of the products; and (vi) future returns can be reasonably estimated. For any sales that do not meet all of the above criteria, revenue is deferred until all such criteria have been met. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for revenue recognition for the sale of goods, which is a transaction between an entity delivering a tangible good to a purchaser. The entity also may disclose its treatment of any unearned or deferred revenue that arises from the transaction. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 15 -URI http://asc.fasb.org/subtopic&trid=2197222 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Product Revenue </Label>
</Row>
<Row FlagID="0">
<Id> 19 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> onvo_RevenueRecognitionResearchAndDevelopmentRevenuePolicyTextBlock </ElementName>
<ElementPrefix> onvo_ </ElementPrefix>
<IsBaseElement> false </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table18 - onvo:RevenueRecognitionResearchAndDevelopmentRevenuePolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Research and Development Revenue Under Collaborative Agreements </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company’s collaboration revenue consists of license and collaboration agreements that contain multiple elements, including non-refundable upfront fees, payments for reimbursement of third-party research costs, payments for ongoing research, payments associated with achieving specific development milestones and royalties based on specified percentages of net product sales, if any. The Company considers a variety of factors in determining the appropriate method of revenue recognition under these arrangements, such as whether the elements are separable, whether there are determinable fair values and whether there is a unique earnings process associated with each element of a contract. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company recognizes revenue from research funding under collaboration agreements when earned on a “proportional performance” basis as research hours are incurred. The Company performs services as specified in each respective agreement on a best-efforts basis, and is reimbursed based on labor hours incurred on each contract. The Company initially defers revenue for any amounts billed or payments received in advance of the services being performed and recognizes revenue pursuant to the related pattern of performance, based on total labor hours incurred relative to total labor hours estimated under the contract. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In December 2010, the Company entered into a 12 month research contract agreement with a third party, whereby the Company was engaged to perform research and development services on a fixed-fee basis for approximately $600,000. Based on the proportional performance criteria, total revenue recognized on the contract from inception through June 30, 2013 was approximately $600,000. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In October 2011, the Company entered into a research contract agreement with a third party, whereby the Company is performing research and development services on a fixed-fee basis for $1,365,000. The agreement included an initial payment to the Company of approximately $239,000 with remaining payments expected to occur over a twenty-one month period. On November 27, 2012, the agreement was amended to include additional research and development services, for an additional $135,000, bringing the total contract value to $1,500,000. This extends the original contract (which runs concurrently) from twenty-one months to twenty-eight months. The Company recorded approximately $94,000 and $259,000 in revenue related to the research contract in recognition of the proportional performance achieved, for the three months ended June 30, 2013 and 2012, respectively. Total revenue recognized on the contract from inception through June 30, 2013 was approximately $1,313,000. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Revenue recognition research and development revenue. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Research and Development Revenue Under Collaborative Agreements </Label>
</Row>
<Row FlagID="0">
<Id> 20 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_RevenueRecognitionMultipleElementArrangements </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table19 - us-gaap:RevenueRecognitionMultipleElementArrangements--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Revenue Arrangements with Multiple Deliverables </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company occasionally enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (“VSOE”) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company recognizes revenue for delivered elements only when it determines there are no uncertainties regarding customer acceptance. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company’s results of operations. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for revenue recognition for multiple-deliverable arrangements including, at a minimum (as applicable): (1) the nature of such arrangements, (2) the significant deliverables within the arrangements, (3) the general timing of delivery or performance of service for the deliverables within the arrangements, (4) performance-, cancellation-, termination- or refund-type provisions, (5) a discussion of the significant factors, inputs, assumptions, and methods used to determine selling price (whether vendor-specific objective evidence, third-party evidence, or estimated selling price) for the significant deliverables, (6) whether the significant deliverables in the arrangements qualify as separate units of accounting and the reasons that they do not qualify as separate units of accounting, if applicable, and (7) the general timing of revenue recognition for significant units of accounting. This element is applicable to all multiple-deliverable arrangements, including software arrangements (for example, software products, upgrades or enhancements, postcontract customer support, or services). </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 25 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=19771336&loc=SL6750900-111635 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=19771336&loc=d3e50766-111635 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Revenue Arrangements with Multiple Deliverables </Label>
</Row>
<Row FlagID="0">
<Id> 21 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> onvo_RevenueRecognitionGrantPolicyTextBlock </ElementName>
<ElementPrefix> onvo_ </ElementPrefix>
<IsBaseElement> false </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table20 - onvo:RevenueRecognitionGrantPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2">NIH and U.S. Treasury Grant Revenues </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> During 2010, the U.S. Treasury awarded the Company two one-time grants totaling approximately $397,000 for investments in qualifying therapeutic discovery projects under section 48D of the Internal Revenue Code. The grants cover reimbursement for qualifying expenses incurred by the Company in 2010 and 2009. The proceeds from these grants are classified in “Revenues — Grants” for the period from inception through June 30, 2013. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">During 2012, 2010 and 2009, the NIH awarded the Company three research grants totaling approximately $558,000. Revenues from the NIH grants are based upon internal and subcontractor costs incurred that are specifically covered by the grants, and where applicable, an additional facilities and administrative rate that provides funding for overhead expenses. These revenues are recognized when expenses have been incurred by subcontractors and as the Company incurs internal expenses that are related to the grants. Revenue recognized under these grants for the three months ended June 30, 2013 and 2012 was approximately $12,000 and $0, respectively. Total revenue recorded under these grants from inception through June 30, 2013 was approximately $558,000. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Revenue recognition grant. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> NIH and U.S. Treasury Grant Revenues </Label>
</Row>
<Row FlagID="0">
<Id> 22 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table21 - us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy--> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Stock-based compensation </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The Company accounts for stock-based compensation in accordance with the Financial Accounting and Standards Board’s ASC Topic 718, <i>Compensation — Stock Compensation,</i> which establishes accounting for equity instruments exchanged for employee services. Under such provisions, stock-based compensation cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense, under the straight-line method, over the employee’s requisite service period (generally the vesting period of the equity grant). </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Company accounts for equity instruments, including restricted stock or stock options, issued to non-employees in accordance with authoritative guidance for equity based payments to non-employees. Stock options issued to non-employees are accounted for at their estimated fair value determined using the Black-Scholes option-pricing model. The fair value of options granted to non-employees is re-measured as they vest, and the resulting increase in value, if any, is recognized as expense during the period the related services are rendered. Restricted stock issued to non-employees is accounted for at their estimated fair value as they vest. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b),(f) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2228939 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Stock-based compensation </Label>
</Row>
<Row FlagID="0">
<Id> 23 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_ComprehensiveIncomePolicyPolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table22 - us-gaap:ComprehensiveIncomePolicyPolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Comprehensive income (loss) </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. The Company is required to record all components of comprehensive income (loss) in the financial statements in the period in which they are recognized. Net income (loss) and other comprehensive income (loss), including unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive income (loss). For the three months ended June 30, 2013 and 2012, and for the period April 19, 2007 (inception) through June 30, 2013, the comprehensive loss was equal to the net loss. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for comprehensive income. </ElementDefenition>
<ElementReferences> No definition available. </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Comprehensive income (loss) </Label>
</Row>
<Row FlagID="0">
<Id> 24 </Id>
<IsAbstractGroupTitle> false </IsAbstractGroupTitle>
<LabelSeparator> </LabelSeparator>
<Level> 2 </Level>
<ElementName> us-gaap_EarningsPerSharePolicyTextBlock </ElementName>
<ElementPrefix> us-gaap_ </ElementPrefix>
<IsBaseElement> true </IsBaseElement>
<BalanceType> na </BalanceType>
<PeriodType> duration </PeriodType>
<IsReportTitle> false </IsReportTitle>
<IsSegmentTitle> false </IsSegmentTitle>
<IsCalendarTitle> false </IsCalendarTitle>
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>
<IsBeginningBalance> false </IsBeginningBalance>
<IsEndingBalance> false </IsEndingBalance>
<IsReverseSign> false </IsReverseSign>
<PreferredLabelRole> verboseLabel </PreferredLabelRole>
<FootnoteIndexer/>
<Cells>
<Cell FlagID="0" ContextID="Apr_01_2013_Jun_30_2013" UnitID="">
<Id> 1 </Id>
<IsNumeric> false </IsNumeric>
<IsRatio> false </IsRatio>
<DisplayZeroAsNone> false </DisplayZeroAsNone>
<NumericAmount> 0 </NumericAmount>
<RoundedNumericAmount> 0 </RoundedNumericAmount>
<NonNumbericText>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: note2_accounting_policy_table23 - us-gaap:EarningsPerSharePolicyTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Net loss per share </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Basic and diluted net loss per share has been computed using the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares used to compute diluted loss per share excludes any assumed exercise of stock options and warrants, the assumed release of restriction of restricted stock units, and shares subject to repurchase as the effect would be anti-dilutive. No dilutive effect was calculated for the three months ended June 30, 2013 or 2012, as the Company reported a net loss for each respective period and the effect would have been anti-dilutive. Total common stock equivalents that were excluded from computing diluted net loss per share were approximately 8.7 million and 25.9 million for the three months ended June 30, 2013 and 2012, respectively. </font></p>
</NonNumbericText>
<FootnoteIndexer/>
<CurrencyCode/>
<CurrencySymbol/>
<IsIndependantCurrency> false </IsIndependantCurrency>
<ShowCurrencySymbol> false </ShowCurrencySymbol>
<DisplayDateInUSFormat> false </DisplayDateInUSFormat>
</Cell>
</Cells>
<ElementDataType> nonnum:textBlockItemType </ElementDataType>
<SimpleDataType> na </SimpleDataType>
<ElementDefenition> Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements. </ElementDefenition>
<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144384 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 </ElementReferences>
<IsTotalLabel> false </IsTotalLabel>
<UnitID> 0 </UnitID>
<Label> Net loss per share </Label>
</Row>
</Rows>
<Footnotes/>
<IsEquityReport> false </IsEquityReport>
<ReportName> Description of Business and Summary of Significant Accounting Policies (Policies) </ReportName>
<MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel>
<SharesRoundingLevel> UnKnown </SharesRoundingLevel>
<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel>
<ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel>
<HasCustomUnits> true </HasCustomUnits>
<IsEmbedReport> false </IsEmbedReport>
<IsMultiCurrency> false </IsMultiCurrency>
<ReportType> Sheet </ReportType>
<RoleURI> http://realestaterestoration.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies </RoleURI>
<NumberOfCols> 1 </NumberOfCols>
<NumberOfRows> 24 </NumberOfRows>
</InstanceReport>

Top
Filing Submission 0001193125-13-329393   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 5:40:15.1pm ET